Figure 2.

Effects of zafirlukast on morning PEF in asthmatic subjects maintained on β₂-agonists alone. Solid line represents zafirlukast and dashed line, placebo. Only data from subjects completing the entire study are illustrated. *p = 0.01 compared to placebo, **p < 0.001 compared to before withdrawal.